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Abstract     
An important contribution to the variability of any proteome is given by the time dimension that should 
be carefully considered to define physiological modifications. To this purpose whole saliva proteome 
was investigated in a wide age range. Whole saliva was collected from 17 preterm newborns with a 
postconceptional age at birth of 178−217 days. In these subjects sample collection was performed 
serially starting immediately after birth and within about 1 year follow-up gathering a total of 111 
specimens. Furthermore, whole saliva was collected from 182 subjects aged between 0 and 17 years 
and from 23 adults aged between 27 and 57 years. The naturally occurring intact salivary proteome of 
the 316 samples was analyzed by low- and high-resolution HPLC-ESI-MS platforms. Proteins peculiar 
of the adults appeared in saliva with different time courses during human development. Acidic 
proline-rich proteins encoded by PRH2 locus and glycosylated basic proline-rich proteins encoded by 
PRB3 locus appeared since 180 days of post-conceptional age, followed at seven months (± two weeks) 
by histatin 1, statherin and P-B peptide. The other histatins and acidic proline-rich proteins encoded by 
PRH1 locus appeared in whole saliva of babies from one to three weeks after the normal term of 
delivery, S-type cystatins appeared at one year (± three months) and basic proline-rich proteins at four 
years (± one year) of age. All the proteinases involved in the maturation of salivary proteins were more 
active in preterm than in at-term newborns, on the basis of the truncated forms detected. The activity of 
the Fam20C kinase, involved in the phosphorylation of various proteins, started around 180 days of 
post-conceptional age, slowly increased reaching values comparable to adults at about two years (± 6 
months) of age. Instead, MAPK14 involved in the phosphorylation of S100A9 was fully active since 
birth also in preterm newborns. 
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1. Introduction 
Human saliva is a bodily fluid very attractive for diagnostic and prognostic purposes because it is 
characterized by an easy and non-invasive specimen collection.1 For this reason in the last years many 
groups have studied by a large variety of –omic platforms human saliva under physiological and 
pathological conditions to evidence new, and possibly early, salivary biomarkers of disease with 
clinical utility as reported in recent outstanding reviews and articles.
2-5
 Sampling of saliva can be 
accomplished without pain and stress for the donor, therefore representing a suitable bodily fluid that 
may be collected and investigated also in pediatric age.6 In the last years our group, as well as other 
ones, investigated the salivary proteome of preterm newborns and subjects in the pediatric age 
highlighting striking differences with respect to adults.
7-11
 By an integrated top-down/bottom-up 
platform we evidenced that uman preterm newborns saliva contains more than forty major salivary 
proteins either undetectable (according to the detection limit of our analytical method) or detectable in 
small amount in saliva of adults.9 On the contrary, the proteins typically revealed in adult were 
undetectable or present in small amount in preterm newborn saliva. In the present study the human 
salivary proteome was investigated in a large group of subjects over a wide range of ages, starting from 
preterm newborns of about 180 days of post-conceptional age (PCA) up to 17 years-old subjects, to 
define the appearance and the level changes of the proteins typically found in adult saliva from the last 
months of fetal development to adulthood. Several post-translational-derived proteoforms have been 
also investigated as a function of age to obtain information on the time course activation of different 
enzymes, in particular kinases and convertases. The present study provides reference data to assess 
whether abnormal expression of salivary proteins and/or anomalous activities of specific enzymes 
involved in post-translational modifications occur during human development. The possibility to easily 
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highlight abnormalities of the salivary proteome, that may be clue of potential diseases, could have a 
significant impact on clinical practice, especially in pediatrics.  
 
2.  Experimental section 
 
2.1 Reagents  
All general chemicals and reagents of LC-MS grade were purchased from J.T.Baker (Deventer, the 
Netherlands), Merck (Darmstadt, Germany) and Sigma Aldrich (St. Louis, MO, USA).  
 
2.2 Subjects enrolled, sample collection and treatment 
The study protocol and written consent form were approved by the Ethical Committees of the 
University Hospital of Cagliari, of the Catholic University of Rome and by the Ethical Committee of 
the Neonatal Intensive Care Unit of the Institute of Clinical Pediatric of the Catholic University of 
Rome and, therefore, it has been performed in accordance with the ethical standards laid down in the 
1964 Declaration of Helsinki. All rules were observed and written consent forms were signed or by the 
donor or by one parent of each child. For ethical reasons, saliva was only collected when sample 
collection caused no stress. 316 samples of resting whole saliva were gathered and analyzed from the 
following subjects:  
a) 17 preterm newborns (8 males, 9 females) with a birth weight ranging between 500 and 1250 g and a 
PCA at birth of 178−217 days (26-31 weeks). Newborns with major congenital malformations or 
prenatal infections were excluded from the study. Sample collection was performed on the same 
preterm newborn during several weeks after birth at fixed time intervals (1 or 2 weeks). When possible, 
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it was also performed after discharge from the neonatal unit, during the periodical check visits within 
about 1 year follow-up. In this way 111 saliva specimens were analyzed covering a period from 178 to 
545 days of PCA. 
b) 182 donors (92 males, 90 females) with an age comprised between 0 to 17 years of age. 
c) 23 adults (10 males, 13 females) with an age comprised between 27 and 57 years.  
Collection time was usually established between 10.00 and 12.00 a.m. The donors were in healthy 
clinical conditions. Except for preterm newborns, donors did not eat or drink 2 h before the collection.  
Whole saliva was collected with a soft plastic aspirator as it flowed into the anterior floor of the mouth. 
After collection, each salivary sample was immediately diluted 1:1 (v/v) with 0.2% aqueous 
2,2,2-trifluoroacetic acid (TFA) in ice bath. The solution was then centrifuged at 8000 g for 5 min 
(4 °C). Finally, the acidic supernatant was separated from the pellet and either immediately analyzed 
with the HPLC-ESI-MS apparatus or stored at -80 °C until the analysis.  
 
2.3 RP-HPLC-ESI-MS analysis  
 
2.3.1 RP-HPLC-high resolution MS/MS characterization of intact protein 
High-resolution HPLC-ESI-MS/MS experiments were carried out by an Ultimate 3000 Nano/Micro 
HPLC apparatus (Dionex, Sunnyvale, CA, USA) equipped with a FLM-3000-Flow manager module 
and coupled to an LTQ Orbitrap XL apparatus (ThermoFisher, San Josè, CA, USA). A Dionex C8 
column (3 µm particle diameter; column dimension 300 µm i.d.×15 cm) or a Zorbax 300 SB-C8 (3.5 
µm particle diameter; column dimension 1 mm i.d.×15 cm) were used as chromatographic columns. 
The following eluents were used: (A) 0.1% (v/v) aqueous formic acid (FA) and (B) 0.01% (v/v) FA in 
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acetonitrile/water 80/20 v/v. The applied gradient was 0–4 min 5% B, 4–34 min from 5 to 50% B 
(linear), 34–64 min from 50 to 90% B (linear), at a flow rate of 80 µL/min. High-resolution positive 
MS/MS spectra were collected in full scan using the lock mass for internal mass calibration 
(polydimethyl cyclosiloxane, 445.1200 m/z) with the resolution of 60000 and 30000, respectively, and 
m/z range from 350 to 2000. In data-dependent acquisition mode the three most intense 
multiply-charged ions were selected and fragmented by using collision induced dissociation (CID, 35% 
normalized collision energy) and spectra were recorded. Alternatively, fragmentation was carried out 
using the same analysis conditions on selected multiply-charged ions corresponding to a specific 
protein mass. Tuning parameters were: capillary temperature 250 °C, source voltage 4.0 kV, capillary 
voltage 48 V, tube lens voltage 170 V. Detailed instrumental operative conditions are reported in 
Supplemental S1. The inject volume was set at 20 µL, corresponding to 10 µL of saliva. 
 
2.3.2 RP-HPLC-low resolution MS analysis of intact protein 
For low resolution (1/6000) MS experiments the HPLC-ESI-IT-MS apparatus used was a Surveyor 
HPLC system (ThermoFisher Scientific) connected by a T splitter to a photo diode-array detector and 
either to an LCQ Advantage ion trap mass spectrometer (ThermoFisher Scientific) or to an LCQ Deca 
XP Plus ion trap mass spectrometer (ThermoFisher Scientific). The chromatographic column was a 150 
× 2.1 mm Vydac (Hesperia, CA, USA) C8 column, with 5-µm particle diameter. The following 
solutions were utilized for the RP-HPLC separation: (eluent A) 0.056% aqueous TFA and (eluent B) 
0.05% TFA in acetonitrile-water 80/20. The gradient applied for the analysis was linear going from 0 to 
55% of B in 40 min, and from 55% to 100% of B in 10 min, at a flow rate of 0.30 mL/min. The T 
splitter permitted 0.20 mL/min to flow toward the diode array detector and 0.10 mL/min to flow toward 
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the ESI source. The UV diode array detector was set at 214 and 276 nm. The MS spray voltage was 4.0 
kV and the capillary temperature was 220 °C. Detailed instrumental operative conditions are reported 
in Supplemental S2. The inject volume was set at 100 µL, corresponding to 50 µL of saliva. 
 
2.4 MS data analysis and statistics  
Deconvolution of averaged ESI-MS and ESI-MS/MS spectra was automatically performed by using 
MagTran 1.0 software
12
 or the HPLC-MS apparatus management software (Xcalibur 2.0.7 SP1, 
Thermo Fisher Scientific). Pearson r coefficient was used to evaluate linear correlations. Differences 
with p value < 0.05 were considered statistically significant. 
 
2.5 Intact protein/peptide characterization and relative quantification 
The different salivary proteins and their proteoforms investigated have been previously characterized 
by means of an integrated top-down/bottom-up proteomic platform.13 The data obtained from high 
resolution ESI-MS and MS/MS utilized for the protein/peptide characterization are summarized in 
Supplemental S3. Salivary peptide and protein quantitative analysis of all the 316 whole saliva 
specimens reported in Section 2.2 was based on the measurement of the low-resolution HPLC-ESI-MS 
eXtracted Ion Current (XIC) peak area (signal/noise ratio > 5). Relative quantification by XIC 
procedure was also carried out by high-resolution HPLC-ESI-MS in selected samples. The percentages 
calculated by high-resolution HPLC-ESI-MS XIC peak areas were in agreement with those calculated 
by low-resolution HPLC-ESI-MS peak areas (within the limit of the experimental error). The XIC 
search reveals the peak associated with the protein of interest by extracting along the total ion current 
(TIC) chromatographic profile the intensity of the ion current of specific multiply-charged ions (m/z) 
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generated by the ESI source. The ions used to quantify the proteins and peptides were carefully 
selected to exclude values in common with other co-eluting analytes. The area of the XIC peak was 
related to the saliva volume (1.0 mL) and it is proportional to protein/peptide concentration, therefore, 
under constant analytical conditions, it can be used for a quantitative analysis and comparative 
studies.
14-16
 The estimated percentage error of the XIC procedure was minor than 8%. 
The m/z values utilized for the determination of the (XIC peak area)/(mL of saliva) of the proteins of 
this study are reported in Supplemental S4. The m/z values of acidic and basic proline-rich proteins, 
histatins, statherin, P-B peptide and S-type cystatins were also reported in our previous study.11 The 
m/z values utilized for the determination of the (XIC peak area)/(mL of saliva) of the different 
proteoforms of S100A9 were already described in reference.
17
 
 
3. Results 
 
3.1 Expression of human salivary proteins in the pediatric age 
HPLC-ESI-MS investigation of the acidic soluble fraction of 293 human whole saliva samples 
collected from preterm newborns (N =111) and from subjects aged 0-17 years (N = 182) highlighted 
some relevant aspects of the human salivary proteome: a) it varies according with the age up to 
adulthood; b) it is characterized by a very high inter-individual variability; c) proteins typically found 
in adults appear in saliva with different time courses d) certain proteoforms were undetectable in saliva 
of preterm and at-term newborns. Therefore, the number of samples utilized for the computation of the 
percentages in the Figures varies for each protein or protein family. 
Some of these features are evident in the Scheme of Fig. 1, which shows the time course expression of 
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the different salivary proteins and peptides investigated in this study and grouped on the basis of their 
locus. Indeed, the thickness of the lines in the scheme gives a rough indication of the percentages of 
protein level at the different ages. In Figure 1 and in all figures displaying temporal changes, a 
logarithmic scale has been used in the abscissa axis to better highlight the major changes occurring in 
preterm newborns in the first weeks after birth, which correspond to the last period of fetal 
development and those occurring immediately after the normal term of delivery and in the first years of 
life. In the scheme, the dashed lines highlights the age range in which proteins were detected in at least 
one baby evidencing the high variability observed in the first period of life. 
 
3.1.1 Acidic proline-rich proteins 
Acidic proline-rich proteins (aPRPs) are a family of salivary proteins encoded by PRH1 and PRH2 loci 
located on chromosome 12p13.2. The majority of individuals in the western population express five 
major isoforms of aPRPs: PIF-s, Db-s (where “s” stands for slow), and Pa (commonly detected as 
2-mer) encoded by the PRH1 locus, PRP-1 and PRP-2, encoded by the PRH2 locus.
18
 PRP-1, PIF-s 
(isobaric, average mass (Mav) 15514 Da) and PRP-2 (Mav 15515 Da) are indistinguishable by 
low-resolution HPLC-ESI-MS analysis, while Db-s (Mav 17633 Da) and Pa 2-mer (Mav 30921 Da) 
can be discriminated.
18
 The proteoforms with Mav 15514-15515 Da were detected even though at 
small amount in all the samples from preterm newborns since 180-190 days of PCA, while Pa 2-mer 
and Db-s have been never detected in preterm newborns before 270-280 days of PCA, that correspond 
to the normal term of delivery. For this reason it was hypothesized that the PRH2 gene expression starts 
during fetal life, slightly before 180 days of PCA, and that of PRH1 gene starts later, after the normal 
term of delivery. 
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3.1.2 Basic proline-rich proteins and glycosylated basic proline-rich proteins  
Basic proline-rich proteins (bPRPs) are the most complex family of salivary proteins secreted only by 
parotid gland. They are the expression product of four genes (PRB1-PRB4) located on chromosome 
12p13.2 closely to the PRH1-2 loci. PRB1 and PRB3 loci exhibit at least four common alleles (S, M, L, 
VL) in the western population, PRB2 locus four (S, M. L(Con1+), L(Con1-)), and PRB4 three (S, M, 
L).
13,19
 As evidenced in Figure 2, bPRPs encoded by PRB1, PRB2 and PRB4 genes are only detectable 
as multiple peptide fragments generated by pre-secretory cleavages of the pro-proteins, and the 
connection between the most common haplotypes and salivary phenotypes is still pending complete 
definition.
13,14,19
 Expression of some bPRPs occurs later with respect to all the other salivary proteins. 
Indeed, non-glycosylated bPRPs were undetectable, or detectable at small amount even in saliva of 
four ± one years old children. Their (XIC peak area)/(mL of saliva) increased with age reaching levels 
comparable to adults only after puberty. A peak attributed to a very heterogeneous mixture of 
glycoforms of bPRPs, whose structure is under characterization in our laboratories, was detected in 
preterm newborn saliva since 180 days of PCA. It is very likely that these glycoforms are the 
expression product of the PRB3 gene, because diverse glycosylated bPRPs are coded by the PRB4 gene 
together with P-D peptide (see Fig. 2) that has never been detected in saliva from newborns. Thus, the 
present data show that the expression of the PRB3 gene occurs early during the last months of fetal life 
and precedes that of the other bPRPs genes (Fig. 1). 
 
3.1.3 Histatins 
The HIS1(or HTN1) and HIS2 (or HTN3) genes, responsible for the expression of histatin 1 (Hst1) and 
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histatin 3 (Hst3), respectively, are closely located on chromosome 4q13.3.
20,21
 From our data we 
assumed that HIS1 protein expression started around seven months (210 days) ± two weeks of PCA. 
Furthermore, as already reported in a recent study, we confirmed that Hst1 showed two maxima of 
concentrations around 1 and 6 years of age, in correspondence with deciduous and permanent 
dentitions.
11
 Concerning Hst3 and its derivatives histatin 6 (Hst6) and histatin 5 (Hst5) the present 
study suggested that HIS2 protein expression commonly starts later than HIS1 roughly after the normal 
term of delivery (270-280 days of PCA).  
 
3.1.4 Statherin and P-B peptide 
STATH and PBII genes located on chromosome 4q13.3 encode statherin, and P-B peptide (also called 
submaxillary gland androgen-regulated protein 3B), respectively.
20,21
 As Hst1, statherin and P-B 
peptide were detected in whole saliva of preterm newborns at seven months (± two weeks) of PCA. 
The increase in concentration with age of the two peptides followed a similar trend. In some preterm 
newborns, both peptides were detected only few days after the normal term of delivery (270-280 days 
of PCA). The (XIC peak area)/(mL of saliva) of the two peptides showed a very significant linear 
correlation coefficient (R = 0.567, N = 193, p < 0.00001) in agreement with the hypothesis that P-B 
peptide is functionally more connected to statherin than to bPRPs.
13,22
 
 
3.1.5 S-type cystatins 
Cystatin S (S1, S2), SN and SA are called S-type cystatins and are the expression products of three loci 
closely located on chromosome 20p.11.21.
21
 In previous studies, it has been shown that they are mainly 
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secreted by submandibular/sublingual glands.
21,22
 S-type cystatins were not detected in any sample 
from preterm and at-term newborns and became detectable at one year (± three months) of age.   
 
3.1.6 S100A9  
S100A9, expression product of a locus located on chromosome 1q21 showed an opposite trend with 
respect to the other proteins investigated.
23
 It belongs to the group of proteins found at high 
concentration in preterm newborn saliva,
9
 that decreased as a function of PCA and became 
undetectable or detectable at low level after the normal term of delivery. 
 
3.2 Post-translational modifications 
 
Age-dependent variations of the relative concentration of post-translationally modified proteoforms of 
salivary proteins can disclose valuable information on the timing of activation of the enzymes involved.  
 
3.2.1 Phosphorylation  
Many phosphorylated proteins related to kinase activities have been detected in human whole saliva by 
bottom-up proteomic studies.
24-26
 The phosphorylation sites of salivary proteins and peptides 
characterized in this study are described in the following sections. 
 
3.2.1.1 Acidic proline-rich proteins 
Ser8 and Ser22 are the main phosphorylation sites of aPRPs. The di-phosphorylated proteins represent 
the major forms, but small amounts of tri-phosphorylated (on Ser17), mono- and non-phosphorylated 
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proteoforms have been also detected in adult human saliva.
18
 In the present study our previous 
observation of the decrease of non-phosphorylated and mono-phosphorylated aPRPs percentages as a 
function of PCA in preterm newborns27 was confirmed on a greater number of subjects. The 
percentages of the different phosphorylated entire aPRPs proteoforms (PRP-1 types, including PRP-1, 
PRP-2 and PIF-s) measured in 263 samples are shown in Fig. 3 as a function of the logarithm of PCA. 
The panels a, b and c show the percentage of non-, mono- and di-phosphorylated aPRPs, respectively. 
The trend lines of Fig. 3 were obtained by fitting experimental data to exponential functions. The mean 
percentage value measured on adults (N = 23) is reported on the right side of all the figures at an 
arbitrary value of 9500 days of PCA. PRP-1 type aPRPs are all cleaved at Arg106 generating truncated 
PRP-3 type proteoforms (including PRP-3, PRP-4 and PIF-f, where “f” stands for fast). Fig. 4a,b,c 
show the percentages of the different phosphorylated proteoforms of truncated PRP-3 type aPRPs 
measured in 258 samples. Figure features are identical to those of Fig. 3. The present data, in 
agreement with previous observations,27 highlight that the kinase involved in the phosphorylation of 
aPRPs is not fully active even at birth and reaches the activity comparable to that of adults at around 
two years of age.  
  
3.2.1.2 Histatin 1  
Hst1 is mono-phosphorylated on Ser2. The HPLC-ESI-MS profile of Fig. 5 shows that the 
non-phosphorylated proteoform eluted close to Hst1 under our experimental conditions.
13,22
 The two 
broad and intense peaks co-eluting with Hst1 correspond to the highly charged aPRPs proteoforms 
(entire 23-24 min, truncated 24-25 min). The percentage of non-phosphorylated Hst1 is reported in Fig. 
6 as a function of the logarithm of PCA. Percentages were calculated from the measured XIC peak area 
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only in 230 samples because Hst1 was not detected in saliva of most of the premature newborns with a 
low PCA. Fig. 6 shows that the activation timing of the kinase responsible for the phosphorylation of 
Hst1 is very similar to the one observed for aPRPs, though Hst1 becomes detectable approximately two 
weeks later than aPRPs.  
 
3.2.1.3 Statherin 
Statherin is di-phosphorylated on Ser1 and Ser2. In the HPLC-ESI-MS profile, the mono- and 
non-phosphorylated proteoforms were detected just before the peak of statherin.13,22 The percentages of 
non- (a), mono- (b) and di-phosphorylated statherin (c) measured in 221 samples are shown in Fig.7 as 
a function of the logarithm of PCA. The trend of phosphorylation of statherin during human 
development was found very similar to that of aPRPs and Hst1.  
 
3.2.1.4 Cystatin S, S1, S2 
Cystatin S1 and S2 correspond to mono-phosphorylated on Ser3 and di-phosphorylated on Ser1 and Ser3 
proteoforms of cystatin S, respectively.
21
 Fig. 8a,b,c shows the percentages of the three proteoforms as 
a function of the logarithm of PCA measured in 124 samples. It is evident that the percentage of the 
three cystatins (cystatin S 6±4 %, S1 68±9 %, S2 26±10 %) does not change in the age range 
investigated.  
 
3.2.1.5 IB-1 and II-2 basic proline-rich proteins 
IB-1 and II-2 are two bPRP peptides, 96 and 75 residues long, respectively, closely eluting in the 
HPLC-ESI-MS profile and sharing very similar sequences and both phosphorylated on Ser8,.
13,19
 These 
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bPRPs are undetectable in whole saliva before 4-6 years of age. When revealed, the phosphorylated 
proteoforms were the prevalent ones, being the non-phosphorylated sporadically detected, as in the 
adults (data not reported). 
 
3.2.1.6 S100A9 
At least four different proteoforms of S100A9 are commonly detectable in human saliva: S100A9 short, 
generated by the loss of the MTCKM N-terminal pentapeptide, S100A9 long, generated by the loss of 
the N-terminal Met residue, and the S-glutathionylated and S-cysteinylated derivatives (on Cys2) of the 
long form, all N-terminally acetylated.
17
 All the S100A9 proteoforms can be phosphorylated on the 
penultimate Thr residue. Fig. 9a shows the percentages of phosphorylation of the short proteoform and 
Fig. 9b the percentage of phosphorylation of all the long proteoforms measured in 187 samples. The 
percentages resulted very similar (mean value 32 ± 6) and did not change as a function of PCA, 
suggesting that the kinase involved in the phosphorylation of S100A9 is fully active since 190 days of 
PCA. 
 
3.2.2.1 Endo- and exo-peptidases: acidic proline-rich proteins 
Different endo- and exo- peptidases work during granule storage and secretion of salivary proteins. 
Among aPRPs, PRP-1, PRP-2, PIF-s and Db-s are cleaved at the Arg106 residue (Arg127 residue in Db-s) 
by the action of a convertase that recognizes the consensus sequence RXXR↓ generating four truncated 
proteoforms called PRP-3, PRP-4, PIF-f and Db-f and a common peptide of 44 amino acid residues 
called P-C peptide.
14,18,21
 The Pa proteoform, due to the substitution Arg103→Cys abolishing the 
RXXR↓ consensus sequence, is not cleaved. It is commonly detected in whole saliva as S-S 2-mer.
18
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As reported in Sections 3.1.1 and 3.2.1.1, PRP-1, PRP-2 and PIF-s (PRP-1 type) as well as their 
truncated derivatives PRP-3, PRP-4 and Pif-f (PRP-3 type, Mav 11162-11163 Da) were detected in 
whole saliva of preterm newborns since 180 days of PCA. The percentage of truncated PRP-3 type 
proteoforms computed with respect to the sum of PRP-1 and PRP-3 type proteoforms measured in 261 
samples is shown in Fig.10a as a function of the logarithm of PCA. Because this percentage is 
indicative of the activity of the convertase responsible for aPRPs cleavage, data in Fig. 10a confirm 
that this enzyme is more active during fetal growth, as previously determined by our group.
27
 
 
3.2.2.2 Endo- and exo-peptidases: histatins 3, 5 and 6 
Hst3 is a small histidine-rich peptide of 32 amino acid residues partially cleaved before granule storage 
at Arg25 by a convertase generating Hst6 (Hst3 fr. 1/25).
22
 The subsequent removal of Arg25 by a 
carboxy-peptidase generates Hst5 (Hst3 fr. 1/24). To evaluate the convertase activity, the percentage of 
Hst5+Hst6 was computed with respect to the sum of Hst3, Hst5 and Hst6 in 192 samples and it is 
shown in Fig. 10b as a function of the logarithm of PCA. Similarly, to evaluate the carboxy-peptidase 
activity, the percentage of Hst5 was computed with respect to the sum of Hst5 and Hst6 in 188 samples 
and it is shown in Fig.10c. From the Figures it is evident that the convertase and the carboxy-peptidase 
activities are high in pre-term newborns and decrease according to PCA reaching the activities 
characteristic of the adults at about one year of age.   
 
3.2.2.3 Endo- and exo-peptidases: S100A9 short and long 
The proteoforms of S100A9 detectable in whole saliva are the short one, and different derivatives of 
the long one.
17
 The percentage of short S100A9 (phosphorylated and non-phosphorylated) with respect 
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to the sum of all the proteoforms of short and long S100A9 (cysteinylated, glutathionylated, 
phosphorylated and non-phosphorylated) measured in 186 samples (Fig. 10d) shows that the 
percentage of S100A9 short increases slightly during human development. 
 
3.2.3 N-terminal acetylation  
The various proteoforms of S100A9 detected in this study are all N-terminally acetylated. It was not 
possible to observe the non-acetylated S100A9 proteoforms even in preterm newborns with less than 
190 days of PCA. This result suggests that the N-terminal acetyltransferase (NAT) responsible for the 
PTM is fully active at 6 months of fetal life.  
 
3.2.4 Sulfation 
Hst1 derivatives with molecular mass increments of 80, 160, 240 and 320 Da corresponding to mono-, 
di-, tri- and tetra-sulfo-tyrosines proteoforms are detectable in whole human saliva. These derivatives 
represent about 10% of total Hst1 being this post-translational modification (PTM) specific of 
submandibular/sublingual gland.
28
 Sulfo-proteoforms of Hst1 appeared in whole saliva during the first 
year of life. They were detected in some newborns few weeks after birth, but they were absent in other 
subjects till one year of age. After one year of age, the sulfo-derivatives were always present in all the 
subjects under study. Therefore, the tyrosylprotein sulfotransferase (TPST) seems to be not active in 
submandibular/sublingual gland during fetal life and its activation seems to occur during the first year 
of life. 
 
4 Discussion  
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4.1 General considerations 
 
An important contribution to the variability of any proteome is given by the physiological 
modifications occurring according to time dimension. The exploration of proteomic temporal changes 
may be defined as “chrono-proteomics”. The present investigation evidenced that individual variability 
of the salivary proteome is very high in the pediatric age, especially in preterm newborns, as shown in 
Figures 3,4 and 6-10. However, the large number of analyzed samples granted a statistical significance 
of the temporal trends observed. Two types of sampling were performed: longitudinal, on 17 preterm 
newborns up to 545 days of PCA for a total of 111 specimens and cross-sectional on subjects aged 
between 0-17 years for a total of 182 specimens. Dashed lines of Fig. 1 represent the age range in 
which specific proteins were detected in at least one baby. The upper limit of this range represents the 
age in which saliva of all the babies displayed the specific protein in the chromatographic profile, even 
if at small amount. Whole saliva of preterm newborns contains a lot of proteins involved in the fetal 
growth, some of them characterized by our group in a previous work.
9
 Many of them pertain to the 
families of S100 proteins, β-thymosins, and cystatins. Several of these proteins have been also detected 
in a large proteomic survey of selected salivary glandular secretions from adults by other groups.
5
 
However, the different proteoforms were not characterized because of the bottom-up platforms applied. 
Concentration of these proteins dropped quickly after birth, and they almost disappeared at the normal 
term of delivery.
9
 In the meantime, proteins typically found in adult saliva became detectable, even 
though with different time courses. aPRPs encoded by PRH2 locus and glycosylated bPRPs encoded by 
PRB3 locus appear first in saliva since 180 days of PCA, followed by Hst1, statherin and P-B peptide 
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that appear at about seven months of PCA. Hst3, Hst5, Hst6 and aPRPs encoded by PRH1 locus appear 
after the normal term of delivery and S-type cystatins at about one year of age. Finally, bPRPs encoded 
by PRB1, PRB2, and PRB4 loci appear not before 3-4 years of age. The hierarchical expression of the 
salivary proteins during human development should have a functional meaning. In this respect, it has 
been suggested that the important modifications observed in Hst1 salivary concentration during infancy 
could be linked to the wound healing and tissue formation properties of this peptide.
29,30
 The late 
appearance of bPRPs, rather than linked to the ability to protect oral cavity against the harmful effects 
of tannins,31 could be connected to changes in diet and taste perception32 and/or perhaps to the 
maturation of secondary sexual traits. The majority of the salivary protein families are probably 
involved in the modulation and selection of the oral and gastrointestinal microbiota that experiences 
deep modifications during pediatric age.
33,34
 Undoubtedly, the role of P-B peptide and its functional 
connection with statherin, the functional meaning of the partial cleavage of aPRPs, as well as the 
significance of the different proteome of the salivary glands are the most challenging questions 
concerning human saliva. The results of this study stimulate further questions on the functions of 
salivary proteins and in the meantime offer new elements to elucidate the role of some of them. 
 
4.2 Phosphorylation 
The similar trend of the level of phosphorylation (see Fig.s 3,4,6) and the common and highly specific 
SxE/pS consensus sequence supported the hypothesis that aPRPs, Hst1 and statherin are all substrates 
of the same kinase.
14
 The kinase, working in the Golgi apparatus of granule secreting cells, was firstly 
defined as Golgi casein kinase and for long time escaped any attempt of purification and structural 
characterization.
35
 Recently, it was recognized as Fam20C, which belongs with Fam20A and B to a 
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family of kinases with sequence similarity, all implicated in the homeostasis of mineralized tissues.
36
  
The results of this study suggested that the expression of this enzyme starts in the salivary glands 
slightly before 200 days of PCA. Its activity slowly increases and reaches values comparable to the 
adults at around two years of age. Fam20C is a pleiotropic enzyme responsible for the phosphorylation 
of a lot of different substrates in many organs and tissues, the central nervous system included.
37
 
Mutations in Fam20C gene in humans cause the Raine syndrome, an extremely rare autosomal 
recessive osteosclerotic bone dysplasia.
38
 The Raine syndrome is usually fatal. In the few cases 
described worldwide, the patients (less than 40) did not survive longer than few weeks after birth. Few 
non-lethal cases have been reported, with great neurological and physiological impairments.
39
 In a 
recent study by our group significant hypo-phosphorylation of aPRPs, statherin and Hst1 in a subgroup 
of patients with autism spectrum disorders has been observed.
40
 The crucial role of Fam20C suggests 
that it has to be strictly synchronized with other enzymes and relevant proteins during development and 
that a small delay in the activation during fetal growth could generate severe neurological 
impairments.
41 
Also cystatin S and the bPRPs IB-1 and II-2 peptides show the consensus sequence 
recognized by Fam20C. The level of phosphorylation of these proteins did not show a trend to increase 
with age, because these proteins appear in human saliva when the enzyme is fully active. S100A9, 
instead, is phosphorylated by MAPK14, a kinase pertaining to the p38 mitogen-activated protein kinase 
pathway.42 Results of Fig. 9 clearly show that this kinase is fully active during the last months of fetal 
growth and its expression largely anticipates that one of Fam20C during fetal development. 
 
4.3 Endo- and exo-peptidases  
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To date, few investigations have been performed in order to characterize proteinases involved in the 
cleavage of salivary proteins.
21
 The principal cleavage consensus sequences are potentially 
recognizable by enzymes pertaining to the furin-like convertase families.14,22 Although the cleavage 
consensus sequences are very similar, it is not known if a common convertase acts on the different 
families of salivary proteins or rather different specific enzymes are involved in the cleavage of each 
protein. bPRPs are completely cleaved before granule storage and the pro-protein is not detectable at 
all in whole saliva. Instead, aPRPs and Hst3 are partially cleaved and a high percentage of the intact 
with respect to the truncated proteoforms can be detected in saliva. Two studies addressed the partial 
characterization of the proteinases acting on aPRPs and bPRPs.
43,44
 A study of Basak and colleagues
45
 
established that Hst3 acts in vitro as substrate for rat PC1 (proprotein convertase 1), but no one study 
was carried out in order to characterize the proteinase in vivo and to establish if the convertase involved 
in the cleavage of PRPs could be the same. Results from the present study evidenced that the activity of 
the convertase/s is higher during the last months of fetal growth (preterm newborn saliva) than after 
birth. We have previously observed this phenomenon in a limited number of subjects in the cleavage of 
aPRPs.
27
 This study confirms this observation in a large number of subjects and highlights a similar 
trend in the cleavage of Hst3 (Fig. 10b). An increased enzymatic activity during the last months of fetal 
growth was also detectable for the carboxy-peptidase involved in the conversion of Hst6 to Hst5 (Fig. 
10c). The removal of C-terminal Arg residues after the convertase cleavage is an event widespread in 
many secretory processes.
46
 In salivary glands this activity could be ascribed to the metalloproteinase 
carboxypeptidase Z,
47
 which is active toward substrates with basic C-terminal amino acids, such as in 
the case of the formation of Hst5 from Hst6.
22 
On the whole, our results suggested that all the 
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proteinases involved in the maturation of salivary proteins are more active during fetal growth, as 
expected in a period of very rapid cell proliferation and tissue growth. 
The relative proportion between short and long S100A9 is probably due to the recognition of similar 
consensus sequences by the enzyme methionine aminopeptidase (MAP), responsible for the removal of 
the initiator methionine after protein synthesis.
48
 A particular N-terminal structural arrangement could 
induce MAP to cleave the fifth instead of the first methionine residue of the protein chain. Figure 10d 
suggests that the MAP recognition slightly changes during development, because the percentage of the 
S100A9 short proteoforms seems to increase a little according to age. Further experiments will be 
necessary to better clarify these results and to establish if the short and long S100A9 proteoforms have 
different functional roles. 
 
4.4 N-terminal acetylation 
N-terminal acetylation is a common protein modification present on more than 80% of cytosolic human 
proteins. It occurs mainly co-translationally by the action of N-terminal acetyltransferases (NATs).
49
 
On the basis of the S100A9 N-terminal residues, a threonine in the long proteoforms and a serine in the 
short proteoforms, the enzyme should be NATa.
49
 From the present data and from our previous 
studies,
9
 NATa as well as any other NATs working on salivary proteins resulted fully active before 7 
months of fetal life. 
 
4.5 Sulfation 
Tyrosine sulfation is a widespread PTM implicated in various cellular and extra-cellular processes.
50
 
Sulfation of tyrosines occurs by the transfer of sulfate from the universal sulfate donor 
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3’-phosphoadenosine 5’-phosphosulfate to the hydroxyl group of tyrosine residues. Until now two 
different tyrosylprotein sulfotransferases (TPST1 and TPST2) have been identified, and all mammalian 
cell types and cell lines studied to date express both.51 Hst1 has been the first sulfo-peptide detected in 
human saliva.
28
 Tyrosines 27, 30, 34, and 36 are involved in the sulfation of Hst1 and the PTM is 
probably hierarchical. Tyr27 satisfies several features required for enzyme recognition, such as the 
presence of two acidic amino acid residues at positions +2 and -4, only one basic residue at -5 position, 
and several turn-inducing amino acid residues (Pro, Ser, Gly, Asn) in the ±7 proximity.
52
 Therefore, 
O-sulfation of Tyr27 in Hst1 may be the first event that activates the sequential sulfation of the other 
three Tyr residues. The results of the present study indicate that in submandibular/sublingual glands  
TPST activity starts during the first year of life. It could be of great interest to establish in the future if 
other fetal organs and tissues show the delayed activation of TPSTs in addition to salivary glands.  
 
5. Acknowledgments 
 
The authors acknowledge the financial support of the Nando Peretti Foundation, the Cagliari 
University, the Catholic University of Rome, the MIUR, the Italian National Research Council (CNR), 
and the Regione Autonoma Sardegna, Fin. 2013, Lg. Reg. N. 7, project "Studio Proteomico della 
Saliva Umana in età pediatrica per la diagnosi precoce delle malattie metaboliche congenite". Morena 
Arba and Monica Sanna gratefully acknowledge Sardinia Regional Government for the financial 
support of their PhD scholarships (P.O.R. Sardegna F.S.E. Operational Programme of the Autonomous 
Region of Sardinia, European Social Fund 2007-2013 - Axis IV Human Resources, Objective l.3, Line 
of Activity l.3.1.). 
Page 25 of 46
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
25 
 
The authors declare no competing financial interest 
 
6. References 
 
(1) Tabak, L. A. A revolution in biomedical assessment: the development of salivary diagnostics. J. 
Dent. Educ. 2001, 65, 1335–1339. 
(2) Wang, Q.; Yu, Q.; Lin, Q.; Duan, Y. Emerging salivary biomarkers by mass spectrometry. Clin. 
Chim. Acta 2015,438,214-221. 
(3) Schafer, C. A; Schafer, J. J, ; Yakob, M.; Lima, P.; Camargo, P.; Wong, D. T. Saliva diagnostics: 
utilizing oral fluids to determine health status. Monogr. Oral Sci. 2014,24,88-98. 
(4) Amado, F. M.; Ferreira, R. P.; Vitorino, R. One decade of salivary proteomics: current 
approaches and outstanding challenges. Clin. Biochem. 2013,46,506-517. 
(5) Denny, P.; Hagen, F. K.; Hardt, M.; Liao, L.; Yan, W.; Arellanno, M.; Bassilian, S.; Bedi, G. S.; 
Boontheung, P.; Cociorva, D.; Delahunty, C. M.; Denny, T.; Dunsmore, J.; Faull, K. F.; Gilligan, J.; 
Gonzalez-Begne, M.; Halgand, F.; Hall, S. C.; Han, X.; Henson, B.; Hewel, J.; Hu, S.; Jeffrey, S.; Jiang, 
J.; Loo, J. A.; Ogorzalek Loo, R. R.; Malamud, D.; Melvin, J. E.; Miroshnychenko, O.; Navazesh, M.; 
Niles, R.; Park, S. K.; Prakobphol, A.; Ramachandran, P.; Richert, M.; Robinson, S.; Sondej, M.; Souda, 
P.; Sullivan, M. A.; Takashima, J.; Than, S.; Wang, J.; Whitelegge, J. P.; Witkowska, H. E.; Wolinsky, 
L.; Xie, Y.; Xu, T.; Yu, W.; Ytterberg, J.; Wong, D. T.; Yates, J. R. 3
rd
; Fisher, S. J. The proteomes of 
human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J 
Proteome Res. 2008, 7, 1994-2006. 
(6) Romano-Keeler, J.; Wynn, J. L.; Maron, J. L. Great expectorations: the potential of salivary 'omic' 
Page 26 of 46
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
26 
 
approaches in neonatal intensive care. J. Perinatol. 2014 ,34,169-173. 
(7) Morzel, M.; Palicki, O.; Chabanet, C.; Lucchi, G.; Ducoroy, P.; Chambon, C.; Nicklaus, S. Saliva 
electrophoretic protein profiles in infants: changes with age and impact of teeth eruption and diet 
transition. Arch. Oral Biol. 2011,56,634-642. 
(8) Morzel, M.; Jeannin, A.; Lucchi, G.; Truntzer, C.; Pecqueur, D.; Nicklaus, S.; Chambon, C.; 
Ducoroy, P. Human infant saliva peptidome is modified with age and diet transition. J Proteomics 
2012,75,3665-3673. 
(9) Castagnola, M.; Inzitari, R.; Fanali, C.; Iavarone, F.; Vitali, A.; Desiderio, C.; Vento, G.; Tirone, C.; 
Romagnoli, C.; Cabras, T.; Manconi, B.; Sanna, M. T.; Boi, R.; Pisano, E.; Olianas, A.; Pellegrini, M.; 
Nemolato, S.; Heizmann, C. W.; Faa, G.; Messana, I. The surprising composition of the salivary 
proteome of preterm human newborn. Mol. Cell. Proteomics 2011, 10, M110.003467. 
(10) Cabras, T.; Pisano, E.; Boi, R.; Olianas, A.; Manconi, B.; Inzitari, R.; Fanali, C.; Giardina, B.; 
Castagnola, M.; Messana, I. Age-dependent modifications of the human salivary secretory protein 
complex. J. Proteome Res. 2009, 8, 4126-4134. 
(11) Manconi, B.; Cabras, T.; Pisano, E.; Sanna, M. T.; Olianas, A.; Fanos, V.; Faa, G.; Nemolato, S.; 
Iavarone, F.; Castagnola, M.; Messana, I. Modifications of the acidic soluble salivary proteome in 
human children from birth to the age of 48 months investigated by a top-down HPLC-ESI-MS platform. 
J. Proteomics 2013, 91, 536-543. 
(12) Zhang, Z.; Marshall, G. A. A universal algorithm for fast and automated charge state 
deconvolution of electrospray mass-to-charge ratio spectra.  J. Am. Soc. Mass Spectrom. 1998, 9, 
225–233.  
(13) Castagnola, M.; Cabras, T.; Iavarone, F.; Vincenzoni, F.; Vitali, A.; Pisano, E.; Nemolato, S.; 
Page 27 of 46
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
27 
 
Scarano, E.; Fiorita, A.; Vento, G.; Tirone, C.; Romagnoli, C.; Cordaro, M.; Paludetti, G.; Faa, G.; 
Messana, I. Top-down platform for deciphering the human salivary proteome. J. Matern. Fetal 
Neonatal Med. 2012, 25 (Suppl 5), 27-43. 
(14) Messana, I.; Inzitari, R.; Fanali, C.; Cabras, T.; Castagnola, M. Facts and artifacts in proteomics of 
body fluids. What proteomics of saliva is telling us? J. Sep. Sci. 2008, 31, 1948-1963. 
(15) Levin, Y.; Schwarz, E.; Wang, L.; Leweke, F. M.; Bahn, S. Labelfree LC-MS/MS quantitative 
proteomics for large-scale biomarker discovery in complex samples. J. Sep. Sci. 2007, 30, 2198−2203. 
(16) Ong, S. E. and Mann, M. Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 
2005, 1, 252–262. 
(17) Castagnola, M.; Cabras, T.; Iavarone, F.; Fanali, C.; Messana, I. Detection of Ca(2+)-binding S100 
proteins in human saliva by HPLC-ESI-MS. Methods Mol. Biol. 2013, 963, 357-371.   
(18) Inzitari, R.; Cabras, T.; Onnis, G.; Olmi, C.; Mastinu, A.; Sanna, M. T.; Pellegrini, M.; Castagnola, 
M.; Messana, I. Different isoforms and post-translational modifications of human salivary acidic 
proline-rich proteins. Proteomics 2005, 5, 805-815. 
(19) Messana, I.; Cabras, T.; Inzitari, R.; Lupi, A.; Zuppi, C.; Olmi, C.; Fadda, M. B.; Cordaro, M.; 
Giardina, B.; Castagnola., M. Characterization of the human salivary basic proline-rich protein 
complex by a proteomic approach. J. Proteome Res. 2004, 3, 792-800. 
(20) Helmerhorst, E. J. and Oppenheim, F. G. Saliva: a dynamic proteome. J. Dent. Res. 2007, 86, 
680-693. 
(21) Oppenheim, F. G.; Salih, E.; Siqueira, W. L.; Zhang, W.; Helmerhorst, E. J. Salivary proteome and 
its genetic polymorphisms. Ann. N.Y. Acad. Sci. 2007, 1098, 22-50.  
(22) Messana, I.; Cabras, T.; Pisano, E.; Sanna, M. T.; Olianas, A.; Manconi, B.; Pellegrini, M.; 
Page 28 of 46
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
28 
 
Paludetti, G.; Scarano, E.; Fiorita, A.; Agostino, S.; Contucci, A. M.; Calò, L.; Picciotti, P. M.; Manni, 
A.; Bennick, A.; Vitali, A.; Fanali, C.; Inzitari, R.; Castagnola, M. Trafficking and post-secretory events 
responsible for the formation of secreted human salivary peptides: a proteomics approach. Mol. Cell. 
Proteomics 2008, 7, 911-926.  
(23) Odink, K.; Cerletti, N.; Bruggen, J.; Clerc, R. G.; Tarcsay, L.; Zwadlo, G.; Gerhards, G.; Schlegel, 
R.; Sorg, C. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 
1987,330,80-82. 
(24) Vitorino, R.; Alves, R.; Barros, A.; Caseiro, A.; Ferreira, R.; Lobo, M. C.; Bastos, A.; Duarte, J.; 
Carvalho, D.; Santos, L. L; and Amado, F. L. Finding new posttranslational modifications in salivary 
proline-rich proteins. Proteomics 2010, 10, 3732-3742.  
(25) Stone, M. D.; Chen, X.; Mc Gowan, T.; Bandhakavi, S.; Cheng, B.; Rhodus, N. L.; Griffin, T.J. 
Large-scale phosphoproteomics analysis of whole saliva reveals a distinct phosphorylation pattern. J. 
Proteome Res. 2011, 10, 1728-1736.  
(26) Salih E.; Siqueira, W. L.; Helmerhorst, E.J.; Oppenheim, F. G. Large-scale phosphoproteome of 
human whole saliva using disulfide-thiol interchange covalent chromatography and mass spectrometry. 
Anal. Biochem. 2010, 407, 19-33. 
(27) Inzitari, R.; Vento, G.; Capoluongo, E.; Boccacci, S.; Fanali, C.; Cabras, T.; Romagnoli, C.; 
Giardina, B.; Messana, I.; Castagnola, M. Proteomic analysis of salivary acidic proline-rich proteins in 
human preterm and at-term newborns. J. Proteome Res. 2007, 6, 1371-1377.  
(28) Cabras, T.; Fanali, C.; Monteiro, J. A.; Amado, F.; Inzitari, R.; Desiderio, C.; Giardina, B.; 
Castagnola, M.; Messana, I. Tyrosine polysulfation of human salivary histatin 1. A post-translational 
modification specific of the submandibular gland. J. Proteome Res. 2007, 6, 2472-2480. 
Page 29 of 46
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
29 
 
(29) Oudhoff, M. J.; Bolscher, J. G.; Nazmi, K.; Kalay, H.; van 't Hof, W.; Amerongen, A. V.; Veerman, 
E. C. Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell 
culture assay. FASEB J. 2008, 22, 3805-3812. 
(30) Brand, H. S.; Ligtenberg, A. J.; and Veerman, E. C. Saliva and wound healing. Monogr Oral Sci. 
2014, 24, 52-60. 
(31) Bennick, A. A. Interaction of plant polyphenols with salivary proteins. Crit. Rev. Oral Biol. Med. 
2002, 13, 184-196. 
(32) Cabras, T.; Melis, M.; Castagnola, M.; Padiglia, A.; Tepper, B. J.; Messana, I.; Tomassini 
Barbarossa, I. Responsiveness to 6-n-propylthiouracil (PROP) is associated with salivary levels of two 
specific basic proline-rich proteins in humans. PLoS One 2012, 7, e30962. 
(33) Guarino, A.; Wudy, A.; Basile, F.; Ruberto, E.; Buccigrossi, V. Composition and role of intestinal 
microbiota in children. J. Matern. Fetal Neonatal Med. 2012, 25 (Suppl 1), 63-66. 
(34) Karlsson, F. H.; Nookaew, I.; Petranovic, D.; Nielsen, J. Prospects for systems biology and 
modeling of the gut microbiome. Trends Biotechnol. 2011, 29, 251-258. 
(35) Brunati, A. M.; Marin, O.; Bisinella, A.; Salviati, A.; Pinna, L. A. Novel consensus sequence for 
the Golgi apparatus casein kinase, revealed using proline-rich protein-1 (PRP1)-derived peptide 
substrates. Biochem. J. 2000, 351, 765-768. 
(36) Tagliabracci, V. S.; Pinna, L. A.; and Dixon, J. E. Secreted protein kinases. Trends Biochem. Sci. 
2013, 38, 121-130.  
(37) Tibaldi, E.; Arrigoni, G.; Brunati, A. M.; James, P.; Pinna, L. A. Analysis of a sub-proteome which 
co-purifies with and is phosphorylated by the Golgi casein kinase. Cell Mol. Life Sci. 2006, 63, 
378-389. 
Page 30 of 46
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
30 
 
(38) Raine, J.; Winter, R. M.; Davey, A.; Tucker, S. M. Unknown syndrome: microcephaly, hypoplastic 
nose, exophthalmos, gum hyperplasia, cleft palate, low set ears, and osteosclerosis. J. Med. Genet. 
1989, 26, 786-788.  
(39) Fradin, M.; Stoetzel, C.; Muller, J.; Koob, M.; Christmann, D.; Debry, C.; Kohler, M.; Isnard, M.; 
Astruc, D.; Desprez, P.; Zorres, C.; Flori, E.; Dollfus, H.; Doray, B. Osteosclerotic bone dysplasia in 
siblings with a Fam20C mutation. Clin. Genet. 2011, 80, 177-183. 
(40) Castagnola, M.; Messana, I.; Inzitari, R.; Fanali, C.; Cabras, T.; Morelli, A.; Pecoraro, A. M.; Neri, 
G.; Torrioli, M. G.; Gurrieri, F. Hypo-phosphorylation of salivary peptidome as a clue to the molecular 
pathogenesis of autism spectrum disorders. J. Proteome Res. 2008, 7, 5327-5332. 
(41) Simpson, M. A.; Scheuerle, A.; Hurst, J.; Patton, M. A.; Stewart, H.; Crosby, A. H. Mutations in 
FAM20C also identified in non-lethal osteosclerotic bone dysplasia. Clin. Genet. 2009, 75, 271-276. 
(42) Lominadze, G.; Rane, M. J.; Merchant, M.; Cai, J.; Ward, R. A.; McLeish, K. R. Myeloid-related 
protein-14 is a p38 MAPK substrate in human neutrophils. J. Immunol. 2005, 174, 7257-7267. 
(43) Azen, E. A.; Amberger, E.; Fisher, S.; Prakobphol, A.; Niece, R. L. PRB1, PRB2, and PRB4 coded 
polymorphisms among human salivary concavalin-A binding, II-1 and Po proline-rich proteins. Am. J. 
Hum. Genet. 1996, 58, 143-153.  
(44) Cai, K.; and Bennick, A. Processing of acidic proline-rich proprotein by human salivary gland 
convertase. Arch. Oral. Biol. 2004, 49, 871-879.  
(45) Basak, A.; Ernst, B.; Brewer, D.; Seidah, N. G.; Munzer, J. S.; Lazure, C.; Lajoie, G. A. 
Histidine-rich human salivary peptides are inhibitors of proprotein convertases furin and PC7 but act as 
substrates for PC1. J. Pept. Res 1997, 49, 596-603.  
(46) Steiner, D. F. The proprotein convertases. Curr. Opin. Chem. Biol. 1998, 2, 31-39. 
Page 31 of 46
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
31 
 
(47) Song, L.; and Fricker, L. D. Cloning and expression of human carboxypeptidase Z, a novel 
metallocarboxypeptidase. J. Biol. Chem. 1997, 272, 10543–10550. 
(48) Lowther, W. T.; and Matthews, B. W. Structure and function of the methionine aminopeptidases. 
Biochim Biophys Acta 2000, 1477, 157-167. 
(49) Starheim, K. K.; Gevaert, K.; Arnesen, T. Protein N-terminal acetyltransferases: when the start 
matters. Trends Biochem. Sci. 2012, 37, 152–161.  
(50) Sasaki, N. Current status and future prospects for research on tyrosine sulfation. Curr. Pharm. 
Biotechnol. 2012, 13, 2632-2641.  
(51) Stone, M. J.; Chuang, S.; Hou, X.; Shoham, M.; Zhu, J. Z. Tyrosine sulfation: an increasingly 
recognised post-translational modification of secreted proteins. N. Biotechnol. 2009, 25, 299-317. 
(52) Monigatti, F.; Hekking, B.; Steen, H. Protein sulfation analysis--A primer. Biochim. Biophys. Acta 
2006, 1764, 1904-1913. 
 
 
 
 
 
 
 
 
 
 
Page 32 of 46
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
32 
 
Legends to Figures 
 
Figure 1 
Scheme describing the approximate time course of the different salivary proteins and peptides 
investigated in this study. The sum of XIC peak areas of all the members belonging to the same family 
of proteins/peptides, grouped on the basis of their locus, is reported as function of age. A logarithmic 
scale has been used in the abscissa axis to better highlight the major changes occurring in preterm 
newborns during the first months of life, which correspond to the last months of fetal development, and 
those occurring immediately after the normal term of delivery and in the first years of life. Dashed lines 
represent the age range in which the proteins were detected in at least one baby. The upper limit of this 
range corresponds to the age in which saliva of all the babies displayed the protein in the 
chromatographic profile, even if at small amount.  
 
Figure 2 
Known bPRPs loci and their phenotypes, according to the most recent mass spectrometry 
characterizations.
13,19
 The nomenclature of the different bPRPs was described by Castagnola et al.
13
   
 
Figure 3 
Percentages of non-phosphorylated (panel a), mono-phosphorylated (panel b) and di-phosphorylated  
(panel c) PRP-1 types aPRPs (comprehending PRP-1, PRP-2 and PIF-s) measured in 263 samples as a 
function of age (logarithmic scale). The trend lines were obtained by fitting experimental data to 
exponential functions. On the right side of the figure the mean value measured in the adults is reported 
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at an arbitrary value of 9500 days of PCA.  
 
Figure 4 
Percentages of non-phosphorylated (panel a), mono-phosphorylated (panel b), and di-phosphorylated 
(panel c) PRP-3 types aPRPs (comprehending PRP-3, PRP-4 and PIF-f) measured in 258 samples as a 
function of age (logarithmic scale). Figure features are identical to those of Fig. 3.  
 
Figure 5 
XIC procedure for the relative quantification of co-eluting proteins/peptides. The upper panel shows 
the HPLC-ESI-MS total ion current profile in the elution range 22.3-26.7 min. The two broad and 
intense peaks are mainly due to the highly charged aPRPs proteoforms (entire at 23-24 min, truncated 
at 24-25 min). The XIC procedure allowed to selectively reveal the current associated to the specific 
ion pertaining to Hst1 (middle panel) and to non-phosphosphorylated Hst-1 (lower panel).  XIC peak 
areas (MA: measured area) are proportional to peptide concentration and were utilized to calculate the 
percentages of the two proteoforms.
14-16
 RT: retention time. NL: normalization level. 
 
Figure 6 
Percentages of non-phosphorylated histatin 1 measured in 230 samples as a function of age 
(logarithmic scale). Figure features are identical to those of Fig. 3.  
 
Figure 7 
Percentages of non-phosphorylated (panel a), mono-phosphorylated (panel b) and di-phosphorylated 
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(panel c) statherin measured in 221 samples as a function of age (logarithmic scale). Figure features are 
identical to those of Fig. 3.  
 
Figure 8 
Percentages of cystatin S (non-phosphorylated; panel a), cystatin S1 (mono-phosphorylated; panel b) 
and cystatin S2 (di-phosphorylated, panel c) measured in 124 samples as a function of age (logarithmic 
scale). Figure features are identical to those of Fig. 3.  
 
Figure 9 
Percentages of non-phosphorylated S100A9 short (panel a) and of all the non-phosphorylated S100A9 
long proteoforms (panel b) measured in 187 samples as a function of age (logarithmic scale). Figure 
features are identical to those of Fig. 3.  
 
Figure 10 
Percentages of truncated PRP-3 type proteoforms with respect to the sum of entire (PRP-1 type) and 
truncated (PRP-3 type) proteoforms measured in 261 samples (panel a). Percentage of Hst5+Hst6 with 
respect to Hst3+Hst5+Hst6 measured in 192 samples (panel b). Percentage of Hst 5 with respect to 
Hst5+Hst6 measured in 188 samples (panel c). Percentage of short S100A9 (phosphorylated and 
non-phosphorylated) with respect to total S100A9 measured in 186 samples (panel d). All percentages 
are as a function of age (logarithmic scale). Other features are identical to those of Fig. 3.  
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Supplemental Files 
 
Supplemental S1 
Tune Method and Instrument Method parameters used for the high-resolution HPLC-MS/MS analyses.  
 
Supplemental S2 
Tune Method and Instrument Method parameters used for the low-resolution HPLC-MS analyses. 
 
Supplemental S3 
MS and MS/MS spectra assignment and characterization of salivary proteins. The “n fragment 
matching” is calculated as the ratio between the number of the experimental fragments yn and bn 
detected and the total principal yn and bn theoretical fragments. The percentage of matching considering 
also all the internal fragments and the possible neutral loss (fragment matching (internal fragments) ) is 
also reported . 
 
Supplemental S4 
Molecular weight (theor), Elution time and m/z values utilized for the manual XIC label-free analyses.  
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Scheme describing the approximate time course of the different salivary proteins and peptides investigated 
in this study. The sum of XIC peak areas of all the members belonging to the same family of 
proteins/peptides, grouped on the basis of their locus, is reported as function of age. A logarithmic scale has 
been used in the abscissa axis to better highlight the major changes occurring in preterm newborns during 
the first months of life, which correspond to the last months of fetal development, and those occurring 
immediately after the normal term of delivery and in the first years of life. Dashed lines represent the age 
range in which the proteins were detected in at least one baby. The upper limit of this range corresponds to 
the age in which saliva of all the babies displayed the protein in the chromatographic profile, even if at small 
amount.  
124x87mm (600 x 600 DPI)  
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Known bPRPs loci and their phenotypes, according to the most recent mass spectrometry 
characterizations.13,19 The nomenclature of the different bPRPs was described by Castagnola et al.13    
130x95mm (600 x 600 DPI)  
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Percentages of non-phosphorylated (panel a), mono-phosphorylated (panel b) and di-phosphorylated  (panel 
c) PRP-1 types aPRPs (comprehending PRP-1, PRP-2 and PIF-s) measured in 263 samples as a function of 
age (logarithmic scale). The trend lines were obtained by fitting experimental data to exponential functions. 
On the right side of the figure the mean value measured in the adults is reported at an arbitrary value of 
9500 days of PCA.  
133x234mm (600 x 600 DPI)  
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Percentages of non-phosphorylated (panel a), mono-phosphorylated (panel b), and di-phosphorylated (panel 
c) PRP-3 types aPRPs (comprehending PRP-3, PRP-4 and PIF-f) measured in 258 samples as a function of 
age (logarithmic scale). Figure features are identical to those of Fig. 3.  
135x252mm (600 x 600 DPI)  
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XIC procedure for the relative quantification of co-eluting proteins/peptides. The upper panel shows the 
HPLC-ESI-MS total ion current profile in the elution range 22.3-26.7 min. The two broad and intense peaks 
are mainly due to the highly charged aPRPs proteoforms (entire at 23-24 min, truncated at 24-25 min). The 
XIC procedure allowed to selectively reveal the current associated to the specific ion pertaining to Hst1 
(middle panel) and to non-phosphosphorylated Hst-1 (lower panel).  XIC peak areas (MA: measured area) 
are proportional to peptide concentration and were utilized to calculate the percentages of the two 
proteoforms.14-16 RT: retention time. NL: normalization level.  
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Percentages of non-phosphorylated histatin 1 measured in 230 samples as a function of age (logarithmic 
scale). Figure features are identical to those of Fig. 3.  
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Percentages of non-phosphorylated (panel a), mono-phosphorylated (panel b) and di-phosphorylated (panel 
c) statherin measured in 221 samples as a function of age (logarithmic scale). Figure features are identical 
to those of Fig. 3.  
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Percentages of cystatin S (non-phosphorylated; panel a), cystatin S1 (mono-phosphorylated; panel b) and 
cystatin S2 (di-phosphorylated, panel c) measured in 124 samples as a function of age (logarithmic scale). 
Figure features are identical to those of Fig. 3.  
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Percentages of non-phosphorylated S100A9 short (panel a) and of all the non-phosphorylated S100A9 long 
proteoforms (panel b) measured in 187 samples as a function of age (logarithmic scale). Figure features are 
identical to those of Fig. 3.  
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Percentages of truncated PRP-3 type proteoforms with respect to the sum of entire (PRP-1 type) and 
truncated (PRP-3 type) proteoforms measured in 261 samples (panel a). Percentage of Hst5+Hst6 with 
respect to Hst3+Hst5+Hst6 measured in 192 samples (panel b). Percentage of Hst 5 with respect to 
Hst5+Hst6 measured in 188 samples (panel c). Percentage of short S100A9 (phosphorylated and non-
phosphorylated) with respect to total S100A9 measured in 186 samples (panel d). All percentages are as a 
function of age (logarithmic scale). Other features are identical to those of Fig. 3.  
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